Navigation Links
Vote for Your Favorite Video! Public Voting Now Open for 2013 Neuro Film Festival
Date:2/7/2013

MINNEAPOLIS, Feb. 7, 2013 /PRNewswire-USNewswire/ -- You can now vote for your favorite video entry to the 2013 Neuro Film Festival at http://www.NeuroFilmFestival.com.  The Neuro Film Festival is a contest by the American Brain Foundation , the foundation of the American Academy of Neurology, to help raise awareness about why more research is needed to cure brain diseases such as Alzheimer's disease, stroke, autism, Parkinson's disease and multiple sclerosis.

Public voting will close on February 14, 2013, with the winner of the "Fan Favorite" award receiving a certificate and recognition at the 2013 Neuro Film Festival in San Diego on March 22, 2013, in conjunction with the American Academy of Neurology's 65th Annual Meeting, the world's largest meeting of neurologists with 10,000 attendees.

A jury will determine the Grand Prize winner and a Runner-Up winner. Both videos will be shown to a live audience at the Neuro Film Festival event.

Learn more about the Neuro Film Festival and cast your vote now at http://www.NeuroFilmFestival.com.

The Neuro Film Festival is sponsored by PSAV® Presentation Services.

The American Brain Foundation supports vital research into finding cures for brain disease. The Foundation is committed to improving patient care, quality of life and public understanding of brain disease. To learn more or to make a donation to support research, visit http://www.CureBrainDisease.org or find us on Facebook, Twitter, Google+ and

SOURCE American Academy of Neurology
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Hemp, Inc.s CEO, Bruce Perlowin, to Speak at Hempcon 2013 Tour on "Hemp and Medical Marijuana Public Company Stocks" and the "Industrial Hemp Industry"
2. KaloBios Pharmaceuticals Completes Initial Public Offering
3. Echo Therapeutics Announces Closing of Public Offering of Common Stock
4. BioElectronics Expands to the Czech & Slovak Republic
5. NewLink Genetics Corporation Announces Exercise of Underwriters Option and Closing of Public Offering of Common Stock
6. KaloBios Pharmaceuticals Announces Pricing of Initial Public Offering
7. Star Scientific Reports Publication of First Peer-Reviewed Article on the Effects of Anatabine in an Animal Model of Multiple Sclerosis
8. Keryx Biopharmaceuticals Announces Pricing of Public Offering of Common Stock
9. Anthera Pharmaceuticals Announces Completion of Public Offering of Common Stock
10. NewLink Genetics Corporation Announces Pricing of Public Offering of Common Stock
11. NewLink Genetics Corporation Announces Proposed Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Md. , May 21, 2013 ... disposable drug-free consumer electronic devices, announced that CEO, ... presenting today to the FDA,s Medical Advisory Committee, ... the company,s products for over the counter sales. ... FDA developed its medical device classification schema," Whelan ...
(Date:5/21/2013)... 21, 2013 Reportlinker.com announces that ... in its catalogue:   ... Optical Coherence Tomography (OCT) ... OBJECTIVES   BCC,s ... offer synopsis of the current and future ...
(Date:5/21/2013)... TARRYTOWN, N.Y. , May 21, 2013 /PRNewswire/ ... Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the ... positive Phase 2a study results of dupilumab (SAR231893/REGN668) in ... monoclonal antibody targeting the alpha subunit of the interleukin ... IL-4 and IL-13, drivers of Th2 (Type 2 helper ...
Breaking Medicine Technology:BioElectronics Presents FDA Reclassification Panel 2BioElectronics Presents FDA Reclassification Panel 3Global Markets and Technologies for Optical Coherence Tomography (OCT) 2Global Markets and Technologies for Optical Coherence Tomography (OCT) 3Global Markets and Technologies for Optical Coherence Tomography (OCT) 4Global Markets and Technologies for Optical Coherence Tomography (OCT) 5Global Markets and Technologies for Optical Coherence Tomography (OCT) 6Global Markets and Technologies for Optical Coherence Tomography (OCT) 7Global Markets and Technologies for Optical Coherence Tomography (OCT) 8Global Markets and Technologies for Optical Coherence Tomography (OCT) 9Global Markets and Technologies for Optical Coherence Tomography (OCT) 10Global Markets and Technologies for Optical Coherence Tomography (OCT) 11Global Markets and Technologies for Optical Coherence Tomography (OCT) 12Global Markets and Technologies for Optical Coherence Tomography (OCT) 13Global Markets and Technologies for Optical Coherence Tomography (OCT) 14Global Markets and Technologies for Optical Coherence Tomography (OCT) 15Global Markets and Technologies for Optical Coherence Tomography (OCT) 16Global Markets and Technologies for Optical Coherence Tomography (OCT) 17Global Markets and Technologies for Optical Coherence Tomography (OCT) 18Global Markets and Technologies for Optical Coherence Tomography (OCT) 19Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 2Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 3Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 4Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 5Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 6Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 7
... N.Y., Dec. 22 Cold Spring Publishing, LLC, announced ... change to Harborside Press, LLC. , In addition, Harborside Press ... over the past year requires a substantial expansion in personnel and ... the new offices of Harborside Press will be located at 37 ...
... , JACKSON, Miss., Dec. 22, 2009 University of ... VISICU e ICU® Program to enhance care of the critically ... in the region to implement the eICU Program, UMHC will serve ... UMHC is using the Philips VISICU eICU Program and ...
Cached Medicine Technology:University of Mississippi Health Care Implements Philips VISICU eICU(R) Program 2University of Mississippi Health Care Implements Philips VISICU eICU(R) Program 3
(Date:5/21/2013)... Spring is the perfect time to get ... with whole foods to weather perfect for outdoor exercise. ... the nutrition experts at Brilliant Nutrition highlight five spring ... 1. Eating Locally, With the abundance of fresh farmers' ... explore, spring is a great time to take advantage ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Standard advice ... test-drive and little else. However given industry’s less than ... to shoppers via the internet, Consumer Mattress Reports sets ... “ Choosing The Best Mattress .” , This article ... tips and suggestions that may not be readily apparent ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Patients of Dr. ... who have lost teeth due to gum disease and would ... for gum disease treatment with laser gum surgery. ... have the highest success rate out of all tooth replacement ... is a relatively new procedure cleared by the Food and ...
(Date:5/21/2013)... BOSTON (May 21, 2013) Prostaglandin analogues (PGAs), drugs ... of treatment for people with glaucoma, but their use ... with blurred vision, dryness, changes in eye color and ... that these drugs also cause upper and lower eyelid ... The findings are described in PLOS ONE . ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 HealthSmart continues ... expanding national presence has required the hiring of new ... HealthSmart is pleased to announce that Dawn Powell has ... serving as the Director of Account Management in the ... offices in Irving, Texas. With extensive client management, employee ...
Breaking Medicine News(10 mins):Health News:Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring 2Health News:Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring 3Health News:Choosing the Best Mattress Simplified in Consumer Mattress Reports’ Latest Article 2Health News:Shenk Dental Care Stimulates Bone Growth for Gum Disease Patients Seeking Dental Implants with Laser Gum Surgery in Atlanta, GA 2Health News:Glaucoma drug can cause droopy eyelids 2Health News:New Talent Joins the HealthSmart Account Management Team 2
... finds 12-month course of valganciclover wards off ... News) -- Extended antiviral treatment after a lung ... rejection, a new study from Duke University Medical ... in lung transplant recipients is cytomegalovirus (CMV), which ...
... the potentially powerful influence of political pressure on ... that use of a largely unproven mammography screening ... cost. Joshua Fenton, assistant professor in the ... with colleagues from the University of Washington and ...
... to new targets, treatments, researcher says , MONDAY, June 14 ... new regions of the human genome that may be related ... in the June issue of the Archives of ... at risk for the devastating dementia just yet, however. , ...
... around 200,000 people in Sweden have been diagnosed with ... be helped by mechanical heart pumps, reveals a thesis ... a total of 99 patients with life-threatening heart failure ... long-term circulatory support., "Two-thirds of these patients survived," says ...
... Men with this history are more prone to hit and ... -- Men who attempted suicide before age 18 are much ... a study from the Oregon Social Learning Center in Eugene. ... neighborhoods who were assessed annually from ages 10 to 32. ...
... According ... within 6 months. Amgen’s Prolia is the newest product to enter the market. Prolia ... ... to a recent analysis by SDI , a leading healthcare market insight and analytics ...
Cached Medicine News:Health News:Longer Antiviral Therapy Reduces Lung Transplant Complications 2Health News:Use of unproven mammography tool soars with Medicare coverage 2Health News:Scientists Spot More Genes Related to Alzheimer's 2Health News:Teen Boys Who Attempt Suicide More Likely to Abuse as Adults 2Health News:SDI Reports: Roughly Half of Patients Prescribed the Most Popular Osteoporosis Drugs Discontinue Therapy Within 6 Months -- Amgen's Prolia Offers New Dosing Option 2
Straight, heavy shafts with 0.12 mm teeth and 5.5 mm tying platform. Wide serrated handle with polished finish....
Straight shafts with 0.12 mm teeth and 5 mm tying platform. Serrated handle with polished finish. Most popular size or model....
Heavy curved shafts with 2 x 2 teeth and crisscross serrated 6 mm tying platform. Serrated handle with polished finish....
Serrated, 10 mm tips angled 30 degrees. Serrated cross action handle with polished finish....
Medicine Products: